Kite Pharma Entered into a Clinical Trial Collaboration with Genentech
Friday, March 18, 2016
Kite Pharma, Inc Collaboration to evaluate safety and efficacy of KTE-C19, in combination with atezolizumab.
A multi-center phase 1b/2 study is expected to begin in 2016.
Entered into a clinical trial collaboration with Genentech, a member of Roche Group.
Source : reuters.com
